Concepedia

M Slavík

MS

Statistics

Publications

14

Citations

597

H-Index

11

Active since

1969

Affiliations

Institute of Pharmacology(Current)

Charles University

Technical University of Liberec

M Slavík is an author at Institute of Pharmacology specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

MedicinePharmacologyPharmacotherapyMedicinal ChemistryPathologyOncologyDrug DiscoveryCancer ResearchClinical StudiesHealth

Publications per year

1969–2024

14

Publications

14

Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis.

Martin D. Abeloff, M Slavík, G D Luk et al. · Journal of Clinical Oncology · 1984 · 146 citations

Pharmaceutical Science, Pathology, Pharmacotherapy +18

Phase I clinical trials.

Carter Sk, Oleg S. Selawry, M Slavík · PubMed · 1977 · 125 citations

Clinical Trial Management, Clinical Trial Analysis, Clinical Endpoint +9

Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.

Daniel D. Von Hoff, John S. Penta, Lee J. Helman et al. · PubMed · 1977 · 124 citations

Drug Safety, Drug-related Deaths, Therapeutic Drug Monitoring +14

Students' reflections on their experience with <scp>ChatGPT</scp>

Josef Šedlbauer, Jan Činčera, M Slavík et al. · Journal of Computer Assisted Learning · 2024 · 50 citations · Full text

Artificial Intelligence, Chatbot, Engineering +16

Phase I clinical studies with WR-2721.

Morton M. Kligerman, Mark Shaw, M Slavík et al. · PubMed · 1980 · 30 citations

Oncology, Radiation Therapy, Weekly Injections +13

1–5 of 14